# GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

> **NCT07660939** · PHASE1 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Plasma Cell Disorders
- Multiple Myeloma (MM)

## Interventions

- **DIAGNOSTIC_TEST:** GPRC5D-Targeted PET/CT Imaging

## Key facts

- **NCT ID:** NCT07660939
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2027-05-25
- **Final completion:** 2027-05-25
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660939, "GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07660939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*